CD38 and atherosclerosis: Thus, from the results of basic research, it appears that CD38 may play a dual role, relating to either anti-atherosclerosis or promoting atherogenesis, depending on the change in sirtuin activity or cADPR- and NAADP-mediated Ca2+ mobilization.